Ekaterina Khammad
Ministry of Health, Russian FederationTitle: Ozone Therapy for Successful Treatment of Patients with COVID-19
Abstract
Aim.
Our
team actively seeks to develop new approaches for treating patients with
COVID-19. The first reports about COVID-19 came out in China in 2019. It was
recognized by WHO as a pandemic crisis on March 11, 2020. Current therapeutic
protocols for COVID-19 vary from one country to another and new comprehensive
approaches are being actively studied.
Material and methods.
We have implemented ozone therapy into clinical practice as an
adjuvant treatment regimen for patients with SARS-CoV-2 infection. In our study,
19 patients received ozone therapy and 18 patients were part of the control
group. All patients had a positive PCR test for SARS-CoV-2 infection and were
matched by the following features: sex, age, severity of
symptoms, imaging data and clinical history. Patients in the study group
received ozone therapy in the form of daily intravenous infusions of ozonized
physiological solution. We used the ozone concentration 2.2-2.4 mg/l.
Conclusion.
We observed a statistically significant improvement in laboratory, radiological
and clinical data of patients in the study group compared to the control group
on the 14th day. Thus, we have demonstrated the benefits of using ozone therapy
in patients with the new coronavirus infection COVID-19. Taking into consideration
the physiological processes underlying such approach, ozone therapy should be
used to treat patients on both phases: the beginning and at the peak of the
disease.
Biography
TBA
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Drop us an email for Program enquiry
primaryhealthcare@scientexconferences.com
General Queries
contact@scientexconferences.com
Sponsors / Exhibiting / Advertising
finance@scientexconferences.com
primaryhealthcare@scientexconferences.com
Our Social Presence
Call us at
USA :(+1) 307 463 7832